Acorda nabs crucial FDA ok for Parkinson ’s drug

Acorda Therapeutics announced that the U.S. FDA approved Inbrija for intermittent treatment of OFF episodes in people with Parkinson ’s disease treated with carbidopa/levodopa.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news